Analysis of Changes in Blood Glucose Spinal Epidural Nerve Block with Steroids in Patients with Low Back Pain

Launched by SUNG HYUN LEE · Feb 7, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how different doses of a medication called dexamethasone, which is used in a procedure to relieve back pain, affect blood sugar levels in patients. The trial will include individuals who have back pain due to issues like spinal stenosis or herniated discs and who also have diabetes or prediabetes. To participate, patients should be planning to receive an epidural steroid injection for their back pain, but those with poorly controlled blood sugar levels won't be eligible.

Participants in the trial will be randomly placed into one of three groups: one will receive no dexamethasone, another will receive a low dose (5 mg), and the last group will receive a higher dose (7.5 mg). To monitor blood sugar levels, participants will wear a device that continuously checks their glucose levels for a few days before the procedure and for a week afterward. This study aims to provide better understanding of how steroid doses affect blood sugar, especially in older patients, and will follow up with participants two weeks later to discuss their pain and blood sugar data.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients need to epidural steroid injection for treating back pain
• • patients diagnosed with diabetes or prediabetes.
• Exclusion Criteria:
• • Patients with poorly controlled blood sugar.(HbA1c\>8.5)